{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:47:19Z","timestamp":1789588039337,"version":"build-2803163510"},"reference-count":93,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The pathogenesis of interstitial lung diseases (ILDs) is significantly influenced by genetic factors, yet lack of consensus on the optimal timing for genetic testing and precise patient selection could hinder clinical practice. Position papers currently suggest testing patients presenting with a suspect of Familial Pulmonary Fibrosis (FPF) and with extra-pulmonary syndromic features (i.e., premature graying, cytopenias, liver cirrhosis) for genetic screening. Diagnostics rely on next-generation sequencing (NGS) to identify pathogenic\/likely pathogenic variants in telomere-related and surfactant-related genes. A specialized genetic consultation is essential in the correct interpretation of test results, especially when variants of uncertain significance (VUS) are detected. Adoption of other tests, such as polygenic risk scores, could further support precision medicine in ILD care. Future research might address the knowledge gap regarding early test prescription and the role of therapy, including lung transplant stratification and antifibrotic therapy, in FPF.<\/jats:p>","DOI":"10.3390\/jcm15134951","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:37:55Z","timestamp":1782391075000},"page":"4951","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Genetic Landscape of Fibrotic Interstitial Lung Diseases: Clinical Implications and Diagnostic Challenges in Familial Pulmonary Fibrosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4502-9902","authenticated-orcid":false,"given":"Claudio","family":"Tirelli","sequence":"first","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Rondinone","sequence":"additional","affiliation":[{"name":"Medical Genetics Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-2573","authenticated-orcid":false,"given":"Fausta","family":"Alfano","sequence":"additional","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4002-7374","authenticated-orcid":false,"given":"Jacopo","family":"Cefalo","sequence":"additional","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5104-7437","authenticated-orcid":false,"given":"Giulia","family":"Nalesso","sequence":"additional","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cirac\u00ec","sequence":"additional","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8484-3661","authenticated-orcid":false,"given":"Carmine","family":"Salerni","sequence":"additional","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Rosa","family":"Miozzo","sequence":"additional","affiliation":[{"name":"Medical Genetics Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Centanni","sequence":"additional","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mondoni","sequence":"additional","affiliation":[{"name":"Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"190053","DOI":"10.1183\/16000617.0053-2019","article-title":"The genetics of interstitial lung diseases","volume":"28","author":"Borie","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2201383","DOI":"10.1183\/13993003.01383-2022","article-title":"European Respiratory Society statement on familial pulmonary fibrosis","volume":"61","author":"Borie","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tirelli, C., Pesenti, C., Miozzo, M., Mondoni, M., Fontana, L., and Centanni, S. (2022). The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123107"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1242\/dmm.010736","article-title":"Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis","volume":"6","author":"Kropski","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nrg3296","article-title":"DNA secondary structures: Stability and function of G-quadruplex structures","volume":"13","author":"Bochman","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.200906-0953OC","article-title":"Surfactant Protein C Mutations Are the Basis of a Significant Portion of Adult Familial Pulmonary Fibrosis in a Dutch Cohort","volume":"182","author":"Barlo","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","first-page":"e2024047","article-title":"The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey","volume":"41","author":"Monteleone","year":"2024","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/15513815.2017.1388456","article-title":"Novel RNASET2 Pathogenic Variants in an East Asian Child with Delayed Psychomotor Development","volume":"37","author":"Sun","year":"2018","journal-title":"Fetal Pediatr. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shen, X., Yi, L., Yi, Y., Yang, J., He, T., and Hu, X. (2015). Dynamic identifying protein functional modules based on adaptive density modularity in protein-protein interaction networks. BMC Bioinform., 16.","DOI":"10.1186\/1471-2105-16-S12-S5"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-15-43","article-title":"A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant","volume":"15","author":"Campo","year":"2014","journal-title":"Respir. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e126125","DOI":"10.1172\/jci.insight.126125","article-title":"An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis","volume":"4","author":"Katzen","year":"2019","journal-title":"JCI Insight"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"200085","DOI":"10.1183\/16000617.0085-2020","article-title":"Genetic disorders of the surfactant system: Focus on adult disease","volume":"30","author":"Grutters","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2301809","DOI":"10.1183\/13993003.01809-2023","article-title":"High risk of lung cancer in surfactant-related gene variant carriers","volume":"63","author":"Brudon","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2213-2600(18)30135-8","article-title":"Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: A candidate gene sequencing study","volume":"6","author":"Dressen","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature12807","article-title":"Muc5b is required for airway defence","volume":"505","author":"Roy","year":"2014","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-021-01750-3","article-title":"Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF","volume":"16","author":"Bonella","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ren, L., Chang, Y.F., Jiang, S.H., Li, X.H., and Cheng, H.P. (2024). DNA methylation modification in Idiopathic pulmonary fibrosis. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1416325"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-019-10066-7","article-title":"Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis","volume":"10","author":"Rubio","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1165\/rcmb.2010-0323OC","article-title":"miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis","volume":"45","author":"Cushing","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Oak, S.R., Murray, L., Herath, A., Sleeman, M., Anderson, I., Joshi, A.D., Coelho, A.L., Flaherty, K.R., Toews, G.B., and Knight, D. (2011). A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021253"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1164\/rccm.200408-1104OC","article-title":"Clinical and pathologic features of familial interstitial pneumonia","volume":"172","author":"Steele","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.rmed.2017.03.020","article-title":"Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns","volume":"126","author":"Bennett","year":"2017","journal-title":"Respir. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1378\/chest.127.6.2034","article-title":"Familial idiopathic pulmonary fibrosis: Clinical features and outcome","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Krauss, E., Gehrken, G., Drakopanagiotakis, F., Tello, S., Dartsch, R.C., Maurer, O., Windhorst, A., von der Beck, D., Griese, M., and Seeger, W. (2019). Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF). BMC Pulm. Med., 19.","DOI":"10.1186\/s12890-019-0895-6"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/13993003.02115-2015","article-title":"Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis","volume":"48","author":"Borie","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Diaz de Leon, A., Cronkhite, J.T., Katzenstein, A.L.A., Godwin, J.D., Raghu, G., Glazer, C.S., Rosenblatt, R.L., Girod, C.E., Garrity, E.R., and Xing, C. (2010). Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010680"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1182\/blood-2010-11-322149","article-title":"Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase","volume":"117","author":"Parry","year":"2011","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.15-0825","article-title":"Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders","volume":"148","author":"Gorgy","year":"2015","journal-title":"Chest"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1378\/chest.10-2865","article-title":"Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations","volume":"140","author":"Cronkhite","year":"2011","journal-title":"Chest"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/rccm.201805-0825OC","article-title":"Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres","volume":"199","author":"Popescu","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13052-025-02110-8","article-title":"A comparative analysis of clinical phenotypes and outcomes in childhood interstitial lung disease due to surfactant dysfunction disorders: Focusing on mutations in SFTPC, ABCA3, and NKX2-1 genes","volume":"51","author":"Tang","year":"2025","journal-title":"Ital. J. Pediatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2008.11.010","article-title":"Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer","volume":"84","author":"Wang","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/hmg\/ddw014","article-title":"Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer","volume":"25","author":"Nathan","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22103","DOI":"10.1074\/jbc.M110.121467","article-title":"Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress","volume":"285","author":"Maitra","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"01348","DOI":"10.1183\/23120541.01348-2024","article-title":"Penetrance of interstitial lung disease and lung cancer in carriers of SFTPA1 or SFTPA2 pathogenic variants","volume":"11","author":"Ducrot","year":"2025","journal-title":"ERJ Open Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000078171","article-title":"Genetic mechanisms of surfactant deficiency","volume":"85","author":"Nogee","year":"2004","journal-title":"Biol. Neonate"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ajmg.a.20670","article-title":"Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease","volume":"126A","author":"Tredano","year":"2004","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/thx.2007.083766","article-title":"Clinical, radiological and pathological features of ABCA3 mutations in children","volume":"63","author":"Doan","year":"2008","journal-title":"Thorax"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MCP.0000000000000680","article-title":"ABCA3 mutations in adult pulmonary fibrosis patients: A case series and review of literature","volume":"26","author":"Klay","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thorax-2022-219434","article-title":"ABCA3-related interstitial lung disease beyond infancy","volume":"78","author":"Li","year":"2023","journal-title":"Thorax"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1002\/humu.21183","article-title":"NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in \u201cBrain-Lung-Thyroid Syndrome\u201d","volume":"31","author":"Guillot","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.12-2502","article-title":"Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1","volume":"144","author":"Hamvas","year":"2013","journal-title":"Chest"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"00356-02021","DOI":"10.1183\/23120541.00356-2021","article-title":"NKX2.1 (TTF1) germline mutation associated with pulmonary fibrosis and lung cancer","volume":"7","author":"Borie","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1172\/JCI85328","article-title":"Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis","volume":"126","author":"Xie","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1900388","DOI":"10.1183\/13993003.00388-2019","article-title":"T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease","volume":"54","author":"Maurac","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41431-023-01413-w","article-title":"Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis","volume":"31","author":"Desroziers","year":"2023","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_50","first-page":"507","article-title":"Heterogeneity in renal cell carcinoma","volume":"35","author":"Beksac","year":"2017","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3346\/jkms.2003.18.4.494","article-title":"Thyroid Transcription Factor-1 (TTF-1) Expression in Human Lung Carcinomas: Its Prognostic Implication and Relationship with Expressions of p53 and Ki-67 Proteins","volume":"18","author":"Myong","year":"2003","journal-title":"J. Korean Med. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12967-025-06447-w","article-title":"Matrix metalloproteinase-driven epithelial-mesenchymal transition: Implications in health and disease","volume":"23","author":"Radisky","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rabinovich, E.I., Kapetanaki, M.G., Steinfeld, I., Gibson, K.F., Pandit, K.V., Yu, G., Yakhini, Z., and Kaminski, N. (2012). Global methylation patterns in idiopathic pulmonary fibrosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033770"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Tirelli, C., Muscato, G., Alaimo, C., Di Leo, I., Mirijaj, S., Pennisi, F., Vancheri, C., and Mondoni, M. (2026). Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies. J. Clin. Med., 15.","DOI":"10.3390\/jcm15114172"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2500158","DOI":"10.1183\/13993003.00158-2025","article-title":"Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS\/ATS Statement","volume":"66","author":"Ryerson","year":"2025","journal-title":"Eur. Respir. J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Tirelli, C., Morandi, V., Valentini, A., La Carrubba, C., Dore, R., Zanframundo, G., Morbini, P., Grignaschi, S., Franconeri, A., and Oggionni, T. (2020). Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00011"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12931-026-03570-0","article-title":"Prevalence and clinical outcomes of fibrotic interstitial lung disease in ANCA associated vasculitis: A single-centre, retrospective, cohort study","volume":"27","author":"Tirelli","year":"2026","journal-title":"Respir. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"240101","DOI":"10.1183\/16000617.0101-2024","article-title":"Rare genetic interstitial lung diseases: A pictorial essay","volume":"33","author":"Borie","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Stock, C.J.W., and Renzoni, E.A. (2021). Telomeres in Interstitial Lung Disease. J. Clin. Med., 10.","DOI":"10.3390\/jcm10071384"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2022.03.023","article-title":"The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work Group","volume":"162","author":"Newton","year":"2022","journal-title":"Chest"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"105135","DOI":"10.1016\/j.ebiom.2024.105135","article-title":"A roadmap to precision treatments for familial pulmonary fibrosis","volume":"104","author":"Hurley","year":"2024","journal-title":"eBioMedicine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2300441","DOI":"10.1183\/13993003.00441-2023","article-title":"Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease","volume":"62","author":"Zhang","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2002872","DOI":"10.1183\/13993003.02872-2020","article-title":"Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis","volume":"57","author":"Adegunsoye","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1164\/rccm.201809-1646OC","article-title":"Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis","volume":"200","author":"Newton","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.healun.2017.02.005","article-title":"Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival","volume":"36","author":"Newton","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.chest.2024.06.006","article-title":"Clinical Impact of Telomere Length Testing for Interstitial Lung Disease","volume":"166","author":"Zhang","year":"2024","journal-title":"Chest"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/resp.70039","article-title":"Impact of A Multidisciplinary Team Discussion for Genetic Lung Fibrosis","volume":"30","author":"Franco","year":"2025","journal-title":"Respirology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.radcr.2020.08.012","article-title":"CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis","volume":"15","author":"Tirelli","year":"2020","journal-title":"Radiol. Case Rep."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gigante, A.R., Tinoco, E.M., Fonseca, A., Marques, I., Sanches, A., Salgueiro, N., Nogueira, C., Campainha, S., and Neves, S. (2023). Use of Next-Generation Sequencing to Support the Diagnosis of Familial Interstitial Pneumonia. Genes, 14.","DOI":"10.3390\/genes14020326"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Bartha, \u00c1., and Gy\u0151rffy, B. (2019). Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology. Cancers, 11.","DOI":"10.3390\/cancers11111725"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Bagger, F.O., Borgwardt, L., Jespersen, A.S., Hansen, A.R., Bertelsen, B., Kodama, M., and Nielsen, F.C. (2024). Whole genome sequencing in clinical practice. BMC Med. Genom., 17.","DOI":"10.1186\/s12920-024-01795-w"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Santos, R., Lee, H., Williams, A., Baffour-Kyei, A., Lee, S.-H., Troakes, C., Al-Chalabi, A., Breen, G., and Iacoangeli, A. (2025). Investigating the Performance of Oxford Nanopore Long-Read Sequencing with Respect to Illumina Microarrays and Short-Read Sequencing. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104492"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Moushib, L.I., Moreno-Ruiz, N., Mart\u00edn-Nalda, A., Rivi\u00e8re, J.G., Urban, B., Dieli-Crimi, R., Perurena-Prieto, J., Aguil\u00f3-Cucurull, A., P\u00e9rez-Est\u00e9vez, E., and Solanich, X. (2026). Exploring the strengths and limitations of AI-driven variant prioritization versus manual curation in inborn errors of immunity. Front. Genet., 17.","DOI":"10.3389\/fgene.2026.1713299"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"100801","DOI":"10.1016\/j.gim.2023.100801","article-title":"Practical considerations for reinterpretation of individual genetic variants","volume":"25","author":"Appelbaum","year":"2023","journal-title":"Genet. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12931-024-03063-y","article-title":"Diagnostic and prognostic implications of family history of fibrotic interstitial lung diseases","volume":"25","author":"Bermudo","year":"2024","journal-title":"Respir. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/ajt.16893","article-title":"Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort","volume":"22","author":"Mal","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1164\/rccm.202505-1054ST","article-title":"Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement","volume":"211","author":"Podolanczuk","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"250046","DOI":"10.1183\/16000617.0046-2025","article-title":"Treating connective tissue disease-associated interstitial lung disease\u2014Think outside the box: A perspective","volume":"34","author":"Khor","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1017\/S204579602200021X","article-title":"Development and psychometric validation of new questionnaires assessing experienced discrimination and internalised stigma among people with Covid-19","volume":"31","author":"Bonetto","year":"2022","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S2213-2600(19)30059-1","article-title":"Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: A prospective validation study","volume":"7","author":"Raghu","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"200067","DOI":"10.1183\/20734735.0067-2020","article-title":"Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples","volume":"16","author":"Crespo","year":"2020","journal-title":"Breathe"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/S2589-7500(22)00230-8","article-title":"Machine learning in radiology: The new frontier in interstitial lung diseases","volume":"5","author":"Barnes","year":"2023","journal-title":"Lancet Digit. Health"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1164\/rccm.202212-2257OC","article-title":"A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities","volume":"208","author":"Moll","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Alonso-Gonz\u00e1lez, A., J\u00e1spez, D., Lorenzo-Salazar, J.M., Delgado, A., Quintero-Bacallado, A., Ma, S.F., Strickland, E., Mychaleckyj, J., Kim, J.S., and Huang, Y. (2026). Polygenic risk scores enhance the identification of carriers of monogenic forms of idiopathic pulmonary fibrosis. medRxiv.","DOI":"10.64898\/2026.04.16.26350967"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ba\u00f1uls, L., Pellicer, D., Castillo, S., Navarro-Garc\u00eda, M.M., Magall\u00f3n, M., Gonz\u00e1lez, C., and Das\u00ed, F. (2020). Gene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082577"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.23736\/S0026-4806.22.08266-0","article-title":"Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease","volume":"115","author":"Piloni","year":"2024","journal-title":"Minerva Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/j.chest.2020.11.074","article-title":"Bilateral Cystic Bronchiectasis as Novel Phenotype of Niemann-Pick Disease Type B Successfully Treated With Double Lung Transplantation","volume":"159","author":"Tirelli","year":"2021","journal-title":"Chest"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Tirelli, C., Rondinone, O., Italia, M., Mira, S., Belmonte, L.A., De Grassi, M., Guido, G., Maggioni, S., Mondoni, M., and Miozzo, M.R. (2024). The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann\u2013Pick Disease: A Comprehensive Review. Biomolecules, 14.","DOI":"10.3390\/biom14020211"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12931-026-03648-9","article-title":"Outcomes of patients with acute exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids: A systematic review and meta-analysis","volume":"27","author":"Mondoni","year":"2026","journal-title":"Respir. Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Carriera, L., Lipsi, R., Dodaj, M., Inchingolo, R., Smargiassi, A., Coppola, A., Mari, P.-V., Barone, R., Ielo, S., and Scala, R. (2026). Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel Pathways. Biomedicines, 14.","DOI":"10.3390\/biomedicines14010154"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1164\/rccm.202401-0238SO","article-title":"Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine","volume":"210","author":"AAdegunsoye","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s10038-022-01020-5","article-title":"Comprehensive genetic analysis using next-generation sequencing for the diagnosis of nephronophthisis-related ciliopathies in the Japanese population","volume":"67","author":"Sakakibara","year":"2022","journal-title":"J. Hum. Genet."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/4951\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:36:27Z","timestamp":1782394587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/4951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":93,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15134951"],"URL":"https:\/\/doi.org\/10.3390\/jcm15134951","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]}}}